{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:50:17Z","timestamp":1761058217576},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.thromres.2005.01.007","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T04:35:31Z","timestamp":1108096531000},"page":"107-111","source":"Crossref","is-referenced-by-count":7,"title":["Antithrombin replacement in neonates: Is there any indication?"],"prefix":"10.1016","volume":"118","author":[{"given":"Dirk","family":"Bassler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2005.01.007_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00001721-200212000-00001","article-title":"Antithrombin: a new look at the actions of a serine protease inhibitor","volume":"13","author":"Roemisch","year":"2002","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2005.01.007_bib2","first-page":"9","article-title":"Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects","volume":"17","author":"Bick","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.thromres.2005.01.007_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1055\/s-0038-1646736","article-title":"Immunologic studies of antithrombin III heparin cofactor in the newborn","volume":"39","author":"Hathaway","year":"1978","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2005.01.007_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","article-title":"Development of the human coagulation system in the full-term infant","volume":"70","author":"Andrew","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.01.007_bib5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V72.5.1651.1651","article-title":"Development of the human coagulation system in the healthy premature infant","volume":"72","author":"Andrew","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.01.007_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3476(85)80308-5","article-title":"Coagulation and fibrinolytic factors in the first week of life in healthy infants","volume":"106","author":"Peters","year":"1985","journal-title":"J. Pediatr."},{"key":"10.1016\/j.thromres.2005.01.007_bib7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF00595913","article-title":"Low antithrombin III: accurate predictor of idiopathic respiratory distress syndrome in premature neonates","volume":"148","author":"van den Berg","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.thromres.2005.01.007_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.74.1.26","article-title":"Role of coagulopathy in newborn intracranial hemorrhage","volume":"74","author":"McDonald","year":"1984","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2005.01.007_bib9","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/0002-9343(89)80532-7","article-title":"Neonatal antithrombin III deficiency","volume":"87","author":"Manco-Johnson","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2005.01.007_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1164\/ajrccm\/145.4_Pt_1.767","article-title":"Thrombin\/antithrombin III complex formation in the neonatal respiratory distress syndrome","volume":"145","author":"Schmidt","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.thromres.2005.01.007_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1203\/00006450-199701000-00019","article-title":"Disease severity is correlated with plasma clotting and fibrinolytic and kinin-kallikrein activity in neonatal respiratory distress syndrome","volume":"41","author":"Brus","year":"1997","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.thromres.2005.01.007_bib12","first-page":"517","article-title":"Surface properties in relation to atelectasis and hyaline membrane disease","volume":"97","author":"Avery","year":"1959","journal-title":"AMA J. Dis. Child."},{"key":"10.1016\/j.thromres.2005.01.007_bib13","series-title":"Effective care of the newborn infant","first-page":"325","article-title":"Respiratory distress syndrome","author":"Soll","year":"1992"},{"key":"10.1016\/j.thromres.2005.01.007_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00001721-199401000-00003","article-title":"Antithrombin III deficiency in neonatal respiratory distress syndrome","volume":"5","author":"Schmidt","year":"1994","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2005.01.007_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1164\/ajrccm.158.2.9712116","article-title":"A placebo-controlled randomised trial of antithrombin therapy in neonatal respiratory distress syndrome","volume":"158","author":"Schmidt","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2005.01.007_bib16","first-page":"288","article-title":"Antithrombin III concentrate in preterm infants with IRDS: an open, controlled randomized clinical trial (abstract)","volume":"62","author":"Muntean","year":"1989","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2005.01.007_bib17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jama.289.9.1124","volume":"289","author":"Schmidt","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2005.01.007_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/adc.59.5.444","article-title":"Intraventricular haemorrhage and haemostasis defects","volume":"59","author":"Beverley","year":"1984","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.thromres.2005.01.007_bib19","series-title":"Perinatal thrombosis and hemostasis","first-page":"225","article-title":"Role of hemostasis in neonatal intracranial hemorrhage","author":"Hathaway","year":"1991"},{"key":"10.1016\/j.thromres.2005.01.007_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000244469","article-title":"Antithrombin-III substitution in preterm infants: effect on intracranial hemorrhage and coagulation parameters","volume":"72","author":"Brangenberg","year":"1997","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.thromres.2005.01.007_bib21","series-title":"Perinatal thrombosis and hemostasis","first-page":"271","article-title":"Antithrombin III administration in premature infants with intracranial hemorrhage","author":"Ikenoue","year":"1991"},{"key":"10.1016\/j.thromres.2005.01.007_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000067005","article-title":"Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?","volume":"83","author":"Fulia","year":"2003","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.thromres.2005.01.007_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-2007-994961","article-title":"Neonatal sepsis: a challenge in hemostaseology","volume":"25","author":"Kreuz","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2005.01.007_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s001340050642","article-title":"Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis","volume":"24","author":"Eisele","year":"1998","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2005.01.007_bib25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"High-dose antithrombin III in severe sepsis. A randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T04:39:36Z","timestamp":1683002376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384805000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0049384805000423"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2005.01.007","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}